SLC1A2
Excitatory amino acid transporter 2
Also known as: EAA2_HUMAN, EAAT2, GLT-1, GLT1, HBGT
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P43004
- Gene
- SLC1A2
- Ensembl
- ENSG00000110436
- Chromosome
- 11
- Canonical length
- 574 aa
- Protein class
- Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters
- Quaternary structure
- Homotrimer
OverviewNCBI Gene
This gene encodes a member of a family of solute transporter proteins. The membrane-bound protein is the principal transporter that clears the excitatory neurotransmitter glutamate from the extracellular space at synapses in the central nervous system. Glutamate clearance is necessary for proper synaptic activation and to prevent neuronal damage from excessive activation of glutamate receptors. Improper regulation of this gene is thought to be associated with several neurological disorders. Alternatively spliced transcript variants of this gene have been identified. [provided by RefSeq, Jun 2017]
Canonical amino-acid sequenceUniProt
574 residues, UniProt reviewed canonical sequence.
>P43004|SLC1A2
1 MASTEGANNM PKQVEVRMHD SHLGSEEPKH RHLGLRLCDK LGKNLLLTLT VFGVILGAVC
61 GGLLRLASPI HPDVVMLIAF PGDILMRMLK MLILPLIISS LITGLSGLDA KASGRLGTRA
121 MVYYMSTTII AAVLGVILVL AIHPGNPKLK KQLGPGKKND EVSSLDAFLD LIRNLFPENL
181 VQACFQQIQT VTKKVLVAPP PDEEANATSA VVSLLNETVT EVPEETKMVI KKGLEFKDGM
241 NVLGLIGFFI AFGIAMGKMG DQAKLMVDFF NILNEIVMKL VIMIMWYSPL GIACLICGKI
301 IAIKDLEVVA RQLGMYMVTV IIGLIIHGGI FLPLIYFVVT RKNPFSFFAG IFQAWITALG
361 TASSAGTLPV TFRCLEENLG IDKRVTRFVL PVGATINMDG TALYEAVAAI FIAQMNGVVL
421 DGGQIVTVSL TATLASVGAA SIPSAGLVTM LLILTAVGLP TEDISLLVAV DWLLDRMRTS
481 VNVVGDSFGA GIVYHLSKSE LDTIDSQHRV HEDIEMTKTQ SIYDDMKNHR ESNSNQCVYA
541 AHNSVIVDEC KVTLAANGKS ADCSVEEEPW KREKLocalizationUniProt · AlphaFold · HPA
Whether an antibody against SLC1A2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 8
- Mean surface accessibility (rSASA)
- 0.33
- Highest tissue expression
- 1,025 nTPM
Expression across tissuesHPA
Tissue
- basal ganglia: 1,025 nTPM
- cerebral cortex: 832 nTPM
- amygdala: 816 nTPM
- hippocampal formation: 432 nTPM
- midbrain: 194 nTPM
- hypothalamus: 152 nTPM
Single-cell type
- astrocytes: 6,365 nCPM
- bergmann glia: 957 nCPM
- syncytiotrophoblasts: 780 nCPM
- oligodendrocyte progenitor cells: 712 nCPM
- rod photoreceptor cells: 700 nCPM
- retinal bipolar cells: 345 nCPM
Immune cell
- basophil: 1.3 nTPM
- neutrophil: 0.4 nTPM
- eosinophil: 0.2 nTPM
- NK-cell: 0.2 nTPM
- classical monocyte: 0.1 nTPM
- gdT-cell: 0.1 nTPM
Brain region
- cerebral cortex: 1,228 nTPM
- basal ganglia: 1,141 nTPM
- hippocampal formation: 887 nTPM
- amygdala: 754 nTPM
- midbrain: 733 nTPM
- thalamus: 677 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about SLC1A2.
Disease | AllUniProt
Conditions SLC1A2 is implicated in, by any mechanism.
- Developmental and epileptic encephalopathy 41 (DEE41) MIM:617105
Disease | GeneticClinVar
10 pathogenic / likely-pathogenic of 539 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Developmental and epileptic encephalopathy, 41
ReferencesPubMed · IEDB
Publications for SLC1A2 from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.
Reference: AutoantibodyPubMed
1 publication
- Autoantibodies against the glial glutamate transporter GLT1/EAAT2 in Type 1 diabetes mellitus-Clues to novel immunological and non-immunological therapies.
2022 · Pharmacol Res · RCR 0.3 · 4 citations
Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.42
- gnomAD pLI
- 0.71
- gnomAD missense Z
- 2.28
- DepMap mean gene effect
- -0.01
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- adult behavior
- cellular response to cocaine
- chemical synaptic transmission
- D-aspartate import across plasma membrane
- glutathione biosynthetic process
- L-aspartate import across plasma membrane
- L-aspartate transmembrane transport
- L-glutamate import across plasma membrane
- L-glutamate transmembrane transport
- monoatomic ion transport
- multicellular organism growth
- neurotransmitter transport
- positive regulation of D-glucose import
- protein homotrimerization
- response to amino acid
- response to wounding
- response to xenobiotic stimulus
- telencephalon development
- transepithelial transport
- transport across blood-brain barrier
- visual behavior
- neurotransmitter reuptake
Molecular functions
- cysteine transmembrane transporter activity
- glutamate:sodium symporter activity
- high-affinity L-glutamate transmembrane transporter activity
- L-glutamate transmembrane transporter activity
- metal ion binding
- monoatomic anion transmembrane transporter activity
- neutral L-amino acid transmembrane transporter activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of SLC1A2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads SLC1A2 as an antibody target. Whether an autoantibody or antibody against SLC1A2 could matter depends on whether native SLC1A2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
SLC1A2 is annotated at the cell surface, where native SLC1A2 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label SLC1A2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...